Latest Research in Drug Transport and Resistance Mechanisms
23 research papers · 2026 median publication year
Top Research Topics in Drug Transport and Resistance Mechanisms
- Gut microbiota and health — 6 papers
- Gout, Hyperuricemia, Uric Acid — 3 papers
- Drug Transport and Resistance Mechanisms — 2 papers
- Liver Disease Diagnosis and Treatment — 2 papers
- Lysosomal Storage Disorders Research — 1 papers
- Cholesterol and Lipid Metabolism — 1 papers
- Coffee research and impacts — 1 papers
- Coenzyme Q10 studies and effects — 1 papers
- Eicosanoids and Hypertension Pharmacology — 1 papers
- Ferroptosis and cancer prognosis — 1 papers
Highest-Cited Papers
- Multi-omics integration of gut microbiome and plasma metabolome in MASLD: a Hainan-based observational case-control study
- Shotgun metagenomic profiling of the fecal microbiome in Lamp2 knockout mice reveals limited genotype-associated differences under standard housing
- Microbiome-host communication via vaccenic acid modulates LRH-1/NR5A2 activity and ameliorates metabolic liver disease
- Phragmites Communis (Lu Gen) Alleviates Hyperuricemia via Xanthine Oxidase Inhibition and Gut-Microbiota-Mediated Metabolite Urate Transporter Regulation
- Suaeda maritima subsp. Salsa (L.) Soó extract attenuates hyperuricemic renal injury by inhibiting the MAPK/NF-κB/NLRP3 pathway
- Phytosterol-induced modulation of gut microbial bile salt hydrolases ameliorates hyperlipidemia via taurohyodeoxycholic acid-mediated FXR antagonism
- From gene to function: unraveling the BSH1-mediated mechanism of Lactobacillus in alleviating intrahepatic cholestasis
- Coffee, the Gut Microbiome, and Host Metabolism: Gastrointestinal Fate, Microbial Transformation, Mechanistic Insights, and Prospects for Precision Nutrition
- Modulation of Hepatic Cholesterol-Related Pathways by Ophiocordyceps sinensis and Coenzyme Q10 in a Sequential Gut–Liver In Vitro Model
- Exploring Hippuric Acid’s Putative Protective Role in Aging through In Silico and In Vitro Screening
- Guardians at the Interface: Microbiota, Intestinal Barriers, and the Gut–Liver Axis in Liver Health and Disease
- Multi-biotics supplementation is associated with partial attenuation of CDAHFD-induced steatotic liver disease in mice: a multi-omics analysis
- Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes
- Gut microbiome and metabolite profiles are associated with subsequent histologic MASH in a longitudinal mouse model
- Gut Microbiota in NAFLD/MASLD: Functional Dysbiosis and the Gut–Liver Axis in Disease Progression
- Icariin-loaded liposomal nanoparticles alleviate streptozotocin-induced diabetic hepatopathy associated with modulation of ferroptosis-related and inflammatory signaling
- Bile Microbiota Profiling in Obese and Non-Obese Patients: A Comparison of Shotgun Metagenomics and 16S rRNA Amplicon Sequencing
- Mapping global research on environmental enteric dysfunction: A bibliometric study of trends and emerging themes
- Perioperative Modulation of the Gut-Liver Axis in Liver Surgery: Clinical Evidence and Future Directions
- Metabolic shifts driven by host‐microbial interactions